Biotech
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 04/13/17 -- Arch Biopartners Inc., (Arch or the Company) (TSX VENTURE: ARCH)(OTCBB: ACHFF) a portfolio-based biotechnology company, today announced that the Cinc ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 04/13/17 -- Calyx Bio-Ventures Inc. (TSX VENTURE: CYX) ("Calyx" or the "Company") is pleased to announce that it has entered into ...
PHILADELPHIA, PA: PHILADELPHIA, PA -- (Marketwired) -- 04/12/17 -- (NASDAQ: GNMX) (the Company) today announced that results identifying a genomic subset of responders from the SAGA trial of AEVI-001 will be presented ...
ROCKVILLE, MD: ROCKVILLE, MD -- (Marketwired) -- 04/12/17 -- , a genetic drug development company, announced the appointment of C. Neil Lyons as Executive Vice President and Chief Financial Officer.Mr. Lyons joins ...
HALIFAX, NOVA SCOTIA: 100 Percent of Healthy Older Adult Volunteers Who Responded to Vaccine Achieved a Sustained Antigen-Specific Immune Response that Remains at Peak One Year Post-Vaccination with DPX-RSV; This Level of ...
BUFFALO, NY: BUFFALO, NY -- (Marketwired) -- 04/11/17 -- (NASDAQ: CBLI) today announced that the Company will webcast its 2017 Annual Meeting of Stockholders on April 21, 2017 at its headquarters in Buffalo, NY.L ...
MUMBAI, INDIA: MUMBAI, INDIA -- (Marketwired) -- 04/11/17 -- Groupe Athena, Inc. (OTC: GATA) announced today revenues of $10,665,210 for the period ending March 31, 2016. Operating income before depreciation, amort ...
SAN DIEGO, CA and MADISON, WI: SAN DIEGO, CA and MADISON, WI -- (Marketwired) -- 04/11/17 -- EAG Laboratories, a global scientific services company that provides testing, analytical and characterization services to technology- and ...
PRAGUE, CZECH REPUBLIC: PRAGUE, CZECH REPUBLIC -- (Marketwired) -- 04/11/17 --Dortmund, Germany and Prague, Czech Republic, April 11, 2017 - The Lead Discovery Center GmbH (LDC), Max Planck Innovation GmbH (MI) and SOTIO a.s ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 04/11/17 -- Immunovaccine Inc. (TSX: IMV)(OTCQX: IMMVF), a clinical stage immuno-oncology company, today announced that University Health Network's (PM) ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 04/10/17 -- Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC)(FRANKFURT: 0E8) announces that ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 04/07/17 -- Immunovaccine Inc. (TSX: IMV)(OTCQX: IMMVF), a clinical stage immuno-oncology company, announced that will present an update on the Company' ...
EDMONTON, ALBERTA: Company reports highest full year revenues in Company's history and continues to deliver strong performance ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 04/06/17 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced its financial results for the first quarter ended February 28, 2017.First quarte ...
CAMBRIDGE, MASSACHUSETTS: CAMBRIDGE, MASSACHUSETTS -- (Marketwired) -- 04/05/17 -- VBI Vaccines Inc. (NASDAQ: VBIV)(TSX: VBV) ("VBI") is scheduled to present updates on two of its programs at the on Tuesday, April ...
HALIFAX, NOVA SCOTIA: Study Part of Ongoing Effort to Identify Novel Combinations of DepoVax(TM)-based Immuno-oncology Candidates to Improve the Responses of Other Novel Immunotherapy Agents ...
GUILDFORD, SURREY: GUILDFORD, SURREY -- (Marketwired) -- 04/04/17 -- Angle PLC (AIM: AGL) (OTCQX: ANPCY)AIM: AGL; OTCQX: ANPCYThe Company has been informed by Lombard Odier Investment Managers group ("Lombard" ...
SEATTLE, WA: SEATTLE, WA -- (Marketwired) -- 04/03/17 -- Atossa Genetics, Inc. (NASDAQ: ATOS) today announced the closing of its previously announced underwritten public offering with gross proceeds to Atossa of ...
SAN FRANCISCO, CA and LONDON, UNITED KINGDOM: SAN FRANCISCO, CA and LONDON, UNITED KINGDOM -- (Marketwired) -- 04/03/17 -- Treos Bio, which is developing precision therapeutic cancer vaccines coupled with companion diagnostics, today announced i ...
